PharmGen Science, Inc. (004720.KS)

KRW 4370.0

(-1.47%)

Annual Balance Sheets

(In KRW)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 335.91 Billion 317.39 Billion 220.32 Billion 135.54 Billion 100.03 Billion 98.19 Billion
Total Current Assets 95.32 Billion 70.54 Billion 77.37 Billion 74.9 Billion 50.61 Billion 80.95 Billion
Cash And Short Term Investments 37.43 Billion 19.88 Billion 34.18 Billion 30.44 Billion 15.92 Billion 45.94 Billion
Cash and Cash Equivalents 36.9 Billion 19.35 Billion 33.65 Billion 25.91 Billion 11.39 Billion 22.41 Billion
Short Term Investments 531.85 Million 531.28 Million 531.08 Million 4.53 Billion 4.53 Billion 23.53 Billion
Net Receivables 36.41 Billion 28.63 Billion 27.04 Billion 27.44 Billion 20.9 Billion 23.01 Billion
Inventory 20.71 Billion 20.9 Billion 15.22 Billion 16.41 Billion 13.78 Billion 12 Billion
Other Current Assets 762.43 Million 1.11 Billion 925.98 Million 585.47 Million 380.00 -90.00
Total Non-Current Assets 240.58 Billion 246.85 Billion 142.94 Billion 60.64 Billion 49.41 Billion 17.23 Billion
Net PPE 41.27 Billion 42.44 Billion 34.9 Billion 17.21 Billion 15.59 Billion 8.61 Billion
Good Will And Intangible Assets 6.41 Billion 6.17 Billion 4.43 Billion 1.93 Billion 1.04 Billion 1.1 Billion
Good Will - - - - 53.74 Million 53.74 Million
Intangible Assets 6.41 Billion 6.17 Billion 4.43 Billion 1.93 Billion 991.66 Million 1.05 Billion
Long-Term Investments 192.88 Billion 186.72 Billion 91.68 Billion 33.17 Billion 21.57 Billion -19.93 Billion
Tax Assets 1.00 -186.72 Billion 11.92 Billion 3.25 Billion 4.29 Billion 3.19 Billion
Other Non Current Assets 10.6 Million 198.22 Billion 5.41 Million 5.06 Billion 6.9 Billion 24.25 Billion
Other Assets - 500.00 - -10.00 - -
Total Liabilities 107.7 Billion 110.27 Billion 93.39 Billion 51.97 Billion 43.78 Billion 41.34 Billion
Total Current Liabilities 63.17 Billion 68.18 Billion 71.12 Billion 37.68 Billion 30.33 Billion 32.96 Billion
Account Payables 4.86 Billion 4.93 Billion 4.5 Billion 4.48 Billion 4.08 Billion 1.86 Billion
Tax Payables 907.6 Million 2.06 Billion 756.28 Million 1.42 Billion 456.22 Million 3.53 Billion
Short Term Debt 37.43 Billion 39 Billion 47.43 Billion 20.38 Billion 18.35 Billion 19.12 Billion
Deferred Revenue 1.01 Billion 994.89 Million 18.25 Billion 11.89 Billion 6.97 Billion 3.53 Billion
Other Current Liabilities 19.85 Billion 23.25 Billion 926.05 Million 925.34 Million 927.64 Million 8.43 Billion
Total Non Current Liabilities 44.53 Billion 42.09 Billion 22.26 Billion 14.28 Billion 13.44 Billion 8.37 Billion
Long-Term Debt 532.33 Million 490.11 Million 577.85 Million 1.01 Billion 1.42 Billion 205.5 Million
Deferred Revenue Non Current 4.00 - 13.92 Billion -3.42 Billion -1.21 Billion -731.22 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 14.98 Billion 13.41 Billion 940.00 13.26 Billion 12.02 Billion 8.17 Billion
Other Liabilities - - - - - -
Total Equity 228.21 Billion 207.11 Billion 126.93 Billion 83.56 Billion 56.24 Billion 56.84 Billion
Stock Holders Equity 228.22 Billion 207.12 Billion 126.93 Billion 83.52 Billion 56.1 Billion 56.74 Billion
Common Stock 9 Billion 7.91 Billion 7.61 Billion 7.35 Billion 5.84 Billion 5.78 Billion
Retained Earnings 138.22 Billion 125.08 Billion 52.97 Billion 20.28 Billion 10.69 Billion 12.27 Billion
Accumulated other comprehensive income 1.51 Billion 2.33 Billion 2.7 Billion -1.33 Billion -79.39 Million -261.24 Million
Common Stock Equity 228.22 Billion 207.12 Billion 126.93 Billion 83.52 Billion 56.1 Billion 56.74 Billion
Capital Lease Obligation 532.33 Million 936.08 Million 1.07 Billion 1.58 Billion 2.17 Billion -
Total Investments 193.42 Billion 187.26 Billion 92.21 Billion 37.7 Billion 26.1 Billion 3.59 Billion
Total Debt 37.96 Billion 39.49 Billion 48 Billion 21.4 Billion 19.77 Billion 19.33 Billion
Net Debt 1.05 Billion 20.13 Billion 14.35 Billion -4.51 Billion 8.38 Billion -3.08 Billion

Balance Sheet Charts